Literature DB >> 24535580

Vaccination against Alzheimer disease: an update on future strategies.

Antonia Fettelschoss1, Franziska Zabel1, Martin F Bachmann2.   

Abstract

Alzheimer disease is a devastating chronic disease without adequate therapy. More than 10 years ago, it was demonstrated in transgenic mouse models that vaccination may be a novel, disease-modifying therapy for Alzheimer. Subsequent clinical development has been a roller-coaster with some positive and many negative news. Here, we would like to summarize evidence that next generation vaccines optimized for old people and focusing on patients with mild disease stand a good chance to proof efficacious for the treatment of Alzheimer.

Entities:  

Keywords:  Abeta; Alzheimer; antibody; third generation; vaccine

Mesh:

Substances:

Year:  2014        PMID: 24535580      PMCID: PMC4896601          DOI: 10.4161/hv.28183

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  31 in total

1.  Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.

Authors:  J-M Orgogozo; S Gilman; J-F Dartigues; B Laurent; M Puel; L C Kirby; P Jouanny; B Dubois; L Eisner; S Flitman; B F Michel; M Boada; A Frank; C Hock
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

2.  The worldwide societal costs of dementia: Estimates for 2009.

Authors:  Anders Wimo; Bengt Winblad; Linus Jönsson
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

Review 3.  Tau as a therapeutic target for Alzheimer's disease.

Authors:  A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

4.  11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

Authors:  Juha O Rinne; David J Brooks; Martin N Rossor; Nick C Fox; Roger Bullock; William E Klunk; Chester A Mathis; Kaj Blennow; Jerome Barakos; Aren A Okello; Sofia Rodriguez Martinez de Liano; Enchi Liu; Martin Koller; Keith M Gregg; Dale Schenk; Ronald Black; Michael Grundman
Journal:  Lancet Neurol       Date:  2010-02-26       Impact factor: 44.182

5.  Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.

Authors:  Christoph Hock; Uwe Konietzko; Andreas Papassotiropoulos; Axel Wollmer; Johannes Streffer; Ruth C von Rotz; Gabriela Davey; Eva Moritz; Roger M Nitsch
Journal:  Nat Med       Date:  2002-10-15       Impact factor: 53.440

6.  The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.

Authors:  Christoph Wiessner; Karl-Heinz Wiederhold; Alain C Tissot; Peter Frey; Simone Danner; Laura H Jacobson; Gary T Jennings; Rainer Lüönd; Rainer Ortmann; Julia Reichwald; Mauro Zurini; Anis Mir; Martin F Bachmann; Matthias Staufenbiel
Journal:  J Neurosci       Date:  2011-06-22       Impact factor: 6.167

Review 7.  Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012).

Authors:  Federica Belluti; Angela Rampa; Silvia Gobbi; Alessandra Bisi
Journal:  Expert Opin Ther Pat       Date:  2013-02-21       Impact factor: 6.674

Review 8.  APP transgenic mice: the effect of active and passive immunotherapy in cognitive tasks.

Authors:  Stephan Röskam; Frauke Neff; Rainer Schwarting; Michael Bacher; Richard Dodel
Journal:  Neurosci Biobehav Rev       Date:  2009-10-24       Impact factor: 8.989

9.  Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

Authors:  N C Fox; R S Black; S Gilman; M N Rossor; S G Griffith; L Jenkins; M Koller
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

10.  Diagnosing Alzheimer's disease: are we any nearer to useful biomarker-based, non-invasive tests?

Authors:  Lydia C B Fletcher; Katie E Burke; Paul L Caine; Natasha L Rinne; Charlotte A Braniff; Hannah R Davis; Kathryn A Miles; Claire Packer
Journal:  GMS Health Technol Assess       Date:  2013-04-11
View more
  8 in total

1.  Vaccination Prevented Short-Term Memory Loss, but Deteriorated Long-Term Spatial Memory in Alzheimer's Disease Mice, Independent of Amyloid-β Pathology.

Authors:  Klaske Oberman; Leonie Gouweleeuw; Peter Hoogerhout; Ulrich L M Eisel; Elly van Riet; Regien G Schoemaker
Journal:  J Alzheimers Dis Rep       Date:  2020-07-23

2.  A cholesterol-lowering VLP vaccine that targets PCSK9.

Authors:  Erin Crossey; Marcelo J A Amar; Maureen Sampson; Julianne Peabody; John T Schiller; Bryce Chackerian; Alan T Remaley
Journal:  Vaccine       Date:  2015-09-26       Impact factor: 3.641

Review 3.  Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease.

Authors:  K Rajasekhar; Thimmaiah Govindaraju
Journal:  RSC Adv       Date:  2018-06-29       Impact factor: 4.036

4.  Periodontitis induced by bacterial infection exacerbates features of Alzheimer's disease in transgenic mice.

Authors:  Naoyuki Ishida; Yuichi Ishihara; Kazuto Ishida; Hiroyuki Tada; Yoshiko Funaki-Kato; Makoto Hagiwara; Taslima Ferdous; Mohammad Abdullah; Akio Mitani; Makoto Michikawa; Kenji Matsushita
Journal:  NPJ Aging Mech Dis       Date:  2017-11-06

5.  Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.

Authors:  Marika Doucet; Aadil El-Turabi; Franziska Zabel; Benjamin H M Hunn; Nora Bengoa-Vergniory; Milena Cioroch; Mauricio Ramm; Amy M Smith; Ariane Cruz Gomes; Gustavo Cabral de Miranda; Richard Wade-Martins; Martin F Bachmann
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 6.  Combination Drug Therapy for the Management of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Abdullah Al Mamun; Philippe Jeandet; Lotfi Aleya; Rasha A Mansouri; Ghulam Md Ashraf; Bijo Mathew; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

7.  Bacterial superglue enables easy development of efficient virus-like particle based vaccines.

Authors:  Susan Thrane; Christoph M Janitzek; Sungwa Matondo; Mafalda Resende; Tobias Gustavsson; Willem Adriaan de Jongh; Stine Clemmensen; Will Roeffen; Marga van de Vegte-Bolmer; Geert Jan van Gemert; Robert Sauerwein; John T Schiller; Morten A Nielsen; Thor G Theander; Ali Salanti; Adam F Sander
Journal:  J Nanobiotechnology       Date:  2016-04-27       Impact factor: 10.435

8.  Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice.

Authors:  Cornelis K Mulder; Yun Dong; Humphrey F Brugghe; Hans A M Timmermans; Wichard Tilstra; Janny Westdijk; Elly van Riet; Harry van Steeg; Peter Hoogerhout; Ulrich L M Eisel
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.